← All organizations

Grupo Mexicano para el Estudios de las Enfermedades Hepaticas

Academic/Hospital

Also known as: Grupo Mexicano para el Estudios de las Enfermedades Hepaticas

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Aug 1, 2019

Timeline

No events for the selected filters.

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

pirfenidone

Indications

Studied for

Recent trials (4)

NCT04099407Lead sponsorPhase 2Aug 1, 2019
NCT04099407Reponsible party - principal investigatorPhase 2Aug 1, 2019
NCT06267794Sponsor investigatorPhase 2Jun 26, 2015
NCT06267794Lead sponsorPhase 2Jun 26, 2015

Details

Last known activity: Aug 1, 2019